Randak Christoph O, Welsh Michael J
Department of Pediatrics, University of Iowa, 500 EMRB, Iowa, IA 52242, USA.
J Bioenerg Biomembr. 2007 Dec;39(5-6):473-9. doi: 10.1007/s10863-007-9119-5.
The cystic fibrosis transmembrane conductance regulator (CFTR) is a Cl(-)channel in the ATP-binding cassette (ABC) transporter protein family. CFTR features the modular design characteristic of ABC transporters, which includes two membrane-spanning domains forming the channel pore, and two ABC nucleotide-binding domains that interact with ATP and contain the enzymatic activity coupled to normal gating. Like other ABC transporters CFTR is an ATPase (ATP + H(2)O --> ADP + Pi). Recent work has shown that CFTR also possesses intrinsic adenylate kinase activity (ATP + AMP left arrow over right arrow ADP + ADP). This finding raises important questions: How does AMP influence CFTR gating? Why does ADP inhibit CFTR current? Which enzymatic activity gates CFTR in vivo? Are there implications for other ABC transporters? This minireview attempts to shed light on these questions by summarizing recent advances in our understanding of the role of the CFTR adenylate kinase activity for channel gating.
囊性纤维化跨膜传导调节因子(CFTR)是ATP结合盒(ABC)转运蛋白家族中的一种氯离子通道。CFTR具有ABC转运蛋白典型的模块化设计特点,包括形成通道孔的两个跨膜结构域,以及两个与ATP相互作用并含有与正常门控相关酶活性的ABC核苷酸结合结构域。与其他ABC转运蛋白一样,CFTR是一种ATP酶(ATP + H₂O → ADP + Pi)。最近的研究表明,CFTR还具有内在的腺苷酸激酶活性(ATP + AMP ⇌ ADP + ADP)。这一发现引发了重要问题:AMP如何影响CFTR门控?为什么ADP会抑制CFTR电流?在体内哪种酶活性控制CFTR门控?这对其他ABC转运蛋白有何影响?本综述试图通过总结我们对CFTR腺苷酸激酶活性在通道门控中作用的最新认识进展来阐明这些问题。